Akums Drugs and Pharmaceuticals Limited Share Price & Analysis

Akums receives ESG rating update

*Akums receives ESG rating update.* The company has disclosed its latest ESG rating in a regulatory filing. This non-financial assessment reflects sustainability and governance practices. **No immediate financial impact** is expected. 📊 *STOCKS:* $AKUMS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ESG

Akums to host investor meet on August 25, 2026

*Akums to host investor meet on August 25, 2026.* The company announced the schedule for its analyst and institutional investor meet. **No financial updates or major announcements** were disclosed in the filing. It is a routine corporate communication ahead of the event. 📊 *STOCKS:* $AKUMS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet

Akums to host analyst and investor meet.

*Akums to host analyst and investor meet.* The event is scheduled to provide updates to institutional investors and analysts. No financial announcements or major developments were indicated. It’s a routine engagement to maintain investor relations. 📊 *STOCKS:* $AKUMS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet

Akums hosts investor call; no major announcements.

*Akums hosts investor call; no major announcements.* The company shared updates during its analyst and institutional investor meet, though no significant financial or operational disclosures were made. Transcript available via NSE corporate filing. Business outlook remains stable with no changes to guidance. 📊 *STOCKS:* $AKUMS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorCall

Akums publishes mandatory newspaper notice

*Akums publishes mandatory newspaper notice.* This is a routine corporate disclosure as required by regulatory norms. No financial or operational updates were provided. Such filings are standard and do not impact business operations. 📊 *STOCKS:* $AKUMS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateFiling

Akums acquires Oriflame India's unit for ₹56 crore

*Akums acquires Oriflame India's manufacturing unit for ₹56 crore.* This marks a strategic diversification beyond pharmaceuticals into FMCG manufacturing. The move expands Akums’ production capabilities and client base in contract manufacturing. **₹56 crore** investment underscores growing vertical integration ambitions. 📊 *STOCKS:* $AKUMS | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Acquisition

Akums to hold 22nd Annual General Meeting

*Akums to hold 22nd Annual General Meeting* as per a newspaper publication notice. The AGM is a routine annual event for shareholders. No major corporate announcements were disclosed in the filing. Details on dividends or key resolutions are awaited. 📊 *STOCKS:* AKUMS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM

Akums shares to see e-voting updates for FY2025-26

*Akums shares to see e-voting updates for FY2025-26*. Akums Drugs and Pharmaceuticals has issued a notice and integrated annual report for FY2025-26 to shareholders without registered email IDs. The move ensures compliance with SEBI’s e-voting and investor communication norms. Physical dispatch may lead to minor administrative costs. 📊 *STOCKS:* AKUMS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AnnualReport

Akums announces 22nd AGM and final dividend details.

*Akums announces 22nd AGM and final dividend details.* The company has released an advertisement informing shareholders about the date and logistics of its 22nd Annual General Meeting. It also confirmed the disbursement of **final and special dividends**, details of which are outlined in the filing. Investors should watch for record and payment dates. 📊 *STOCKS:* AKUMS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Dividend

Akums to host analyst and investor meet

*Akums to host analyst and investor meet* to discuss business updates and strategy. The company has scheduled an investor/analyst meeting, as per a regulatory filing. Such events often provide clarity on guidance and operational performance. No financial figures or major announcements were disclosed. 📊 *STOCKS:* AKUMS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Pharma